Electrocardiography Should Be Considered for Nocturnal Enuresis
WEDNESDAY, April 13, 2022 (HealthDay News) — In the case of unexplained nocturnal enuresis, electrocardiography should be considered as part of the diagnostic workup, according to a creative concepts article published online April 6 in Heart Rhythm.A…
Learn MoreU.S. Life Expectancy Dropped Between 2019 and 2020
WEDNESDAY, April 13, 2022 (HealthDay News) — U.S. life expectancy decreased between 2019 and 2020, on a larger scale than seen in 21 other high-income countries, according to a study published online April 13 in JAMA Network Open.Steven H. Woolf, M.D…
Learn MoreLong-Term QOL Examined for Surgical Choices in Breast Cancer
WEDNESDAY, April 13, 2022 (HealthDay News) — Among women receiving treatment for early-stage breast cancer, mastectomy and reconstruction without radiation therapy (RT) is associated with similar breast satisfaction and physical well-being, but worse…
Learn MoreStudies Look at Meningitis Vaccine for Preventing Gonorrhea
WEDNESDAY, April 13, 2022 (HealthDay News) — Meningitis vaccine might provide some protection against gonorrhea, according to three studies published online April 12 in The Lancet Infectious Diseases.
Winston E. Abara, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues identified laboratory-confirmed gonorrhea and chlamydia infections among individuals aged 16 to 23 years from New York City and Philadelphia in 2016 to 2018. Case records were linked to immunization registry records to determine serogroup B meningococcal outer membrane vesicle vaccine (MenB-4C) vaccination status at infection. The researchers found that of the 109,737 individuals with 167,706 infections, 7,692 were vaccinated, of whom 52.4, 46.7, and
Bing Wang, Ph.D., from the Women’s and Children’s Health Network in Adelaide, Australia, and colleagues examined vaccine effectiveness and the impact of the four-component serogroup B meningococcal (4CMenB) vaccine two years after implementation in 2018 (for infants and children aged 0 to 3 years) and 2019 (for children and young adults aged 15 to 20 years). The researchers found that the estimated two-dose vaccine effectiveness was 32.7 percent against gonorrhea in adolescents and young adults, using age-matched individuals with chlamydia as controls. In a third study, Lilith K. Whittles, Ph.D., from Imperial College London, and colleagues assessed the cost-effectiveness of vaccination against gonorrhea among men who have sex with men in England. They note that 4CMenB administered under a vaccination according to risk strategy would likely be cost-saving, averting an estimated mean of 110,200 cases and saving a mean of £7.9 million over 10 years.
“Future development of gonorrhea-specific vaccines should prioritize increasing efficacy over duration of protection,” Whittles and colleagues write.
Several authors from the Wang study disclosed financial ties to the pharmaceutical industry. One author from the Whittles study disclosed ties to Pfizer.
Abstract/Full Text – Abara (subscription or payment may be required)
Abstract/Full Text – Wang (subscription or payment may be required)
Abstract/Full Text – Whittles (subscription or payment may be required)
Editorial (subscription or payment may be required)
Learn MoreACC: Empagliflozin Offers Clinical Benefit in Heart Failure
WEDNESDAY, April 13, 2022 (HealthDay News) — For patients hospitalized for acute heart failure, treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin produces clinical benefit, according to a study published online April 4…
Learn MoreMenopausal Age, Obesity Links to Heart Failure Explored
WEDNESDAY, April 13, 2022 (HealthDay News) — The risk for heart failure is increased with increasing body mass index and waist circumference, especially for those with menopausal age 55 years or older, according to a study published online April 13 i…
Learn MoreSentinel Node Biopsy Questioned for Some Older Women With Breast Cancer
WEDNESDAY, April 13, 2022 (HealthDay News) — Positive lymph node status is not a reliable indicator of the need for adjunctive chemotherapy, and sentinel node biopsy may not be helpful in older women with certain low-risk breast cancers, according to…
Learn MoreSurgery Type Does Not Impact Breast Cancer Survival in Younger Patients
WEDNESDAY, April 13, 2022 (HealthDay News) — Overall survival does not differ based on type of surgery in younger patients with breast cancer, according to a study presented at the annual meeting of the American Society of Breast Surgeons, held from …
Learn MoreAdding Pulse Oximetry Shows No Benefit in COVID-19
WEDNESDAY, April 13, 2022 (HealthDay News) — The addition of home pulse oximetry to remote monitoring does not improve the number of days alive and out of the hospital among patients with COVID-19, according to a research letter published online Apri…
Learn MoreNon-Hispanic Black Patients More Likely to Have Diabetic Ketoacidosis
WEDNESDAY, April 13, 2022 (HealthDay News) — Non-Hispanic Black individuals with type 1 diabetes (T1D) are more likely to have diabetic ketoacidosis (DKA), and this disparity was seen in 2019 and persisted during the COVID-19 pandemic in 2020, accord…
Learn More
English
Spanish